MYO Overview

Myomo, Inc. is a wearable medical robotics company that offers improved arm and hand function for those suffering from neurological disorders and upper-limb paralysis. The Company develops and markets the MyoPro product line, which is a myoelectric-controlled upper limb brace, or orthosis. MyoPro is a powered upper-limb orthosis designed to support the arm and restore function to the weakened or paralyzed arms of certain patients suffering from CVA stroke, brachial plexus injury, traumatic brain or spinal cord injury or other neuromuscular disease or injury. MyoPro senses a patient’s own electromyography (EMG) signals through non-invasive sensors on the arm and can restore an individual’s ability to perform activities of daily living, including feeding themselves, carrying objects and doing household tasks. MyoPro’s control technology utilizes an advanced human-machine interface based on non-invasive, patented electromyography, or EMG, control technology.

Wall Street analysts forecast MYO stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for MYO is5.75 USD with a low forecast of 4.00 USD and a high forecast of 10.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

Myomo Inc revenue for the last quarter amounts to 11.35M USD, decreased -5.93

Myomo Inc. EPS for the last quarter amounts to -0.09 USD, increased 800.00

Myomo Inc (MYO) has 194 emplpoyees as of March 16 2026.

Today MYO has the market capitalization of 26.83M USD.